• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Does a novel hypoxic cell radiosensitizer RK28 cysteine conjugate have tumor affinity in vivo?

Research Project

Project/Area Number 10670853
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionYamaguchi University

Principal Investigator

EBE Kazuyu  Yamaguchi University Hospital, Assistant Professor, 医学部・附属病院, 講師 (90213579)

Co-Investigator(Kenkyū-buntansha) MATSUNAGA Naofumi  Yamaguchi University School of Medicine, Professor, 医学部, 教授 (40157334)
KARINO Yuichi  Yamaguchi University Hospital, Research Associate, 医学部・附属病院, 助手 (30186035)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2000: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1999: ¥300,000 (Direct Cost: ¥300,000)
Fiscal Year 1998: ¥2,800,000 (Direct Cost: ¥2,800,000)
Keywordsradiation / hypoxic cell / radiosensitizer / chromatography
Research Abstract

We have reported that RK28 cysteine conjugate (metabolite e) might be a novel hypoxic cell radiosensitizer as its concentration in tumor was higher than in serum on the rabbit VX2 tumor system. In this study, we report the results of its isolation and collection from rabbit urine after RK28 intravenous injection and pharmacokinetic studies for RK28 cysteine conjugate on the nude mouse KM1 human oral cancer system.
(1) RK28 and major metabolites were analyzed using high performance liquid chromatography (HPLC) with tetrabutylammonium phosphate solution (TBAP). RK28 cysteine conjugate was isolated using a LH20 column, a G10 column, and an ODS column without TBAP.A total amount of 211 μg was collected.
(2) The nude mouse KM1 human oral cancer system was newly developed for pharmacokinetic studies for RK28 cysteine conjugate
(3) Concentrations of RK28 cysteine conjugate in KM1 tumor, in serum, in urine of 2 nude mice after intravenous injection were analyzed, but it was not detected. It seems that administration doses were too little
(4) Collection methods for RK28 cysteine conjugate and a newly developed nude mouse KM1 tumor system were publicated.

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] 江部和勇: "ヒト頭頚部癌KM1細胞のヌードマウス移植生着率向上のための方法-in vivo-in vivo移植系について-"臨床と研究. 77(9). 1731-1732 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 江部和勇: "放射線増感剤RK28システイン抱合体-その分離と分取について-"山口医学. 49(5). 491-496 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kazuyu Ebe, et al.: "In vivo-in vivo transplantation of human oral cancer KM1 tumor on nude mice."Rinshou To Kenkyu. 77 (9). 1731-1732 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kazuyu Ebe, et al.: "Hypoxic Cell Radiosensitizer RK28 Cysteine Conjugate -Its Isolation and Collection-"Yamaguchi Medical Journal. 49 (5). 491-496 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 江部和勇: "ヒト頭頚部癌KM1細胞のヌードマウス移植生着率向上のための方法-in vivo-in vivo移植系について"臨床と研究. 77(9). 1731-1732 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 江部和勇: "放射線増感剤RK28システイン抱合体-その分離と分取について-"山口医学. 49(5). 491-496 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi